MedTrace Logo

Clinical Applications of Domperidone in Patients With Delayed Gastric Emptying

NCT01844622 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 37

Last updated 2017-05-16

No results posted yet for this study

Summary

The purpose of the study is to treat patients with on-going slow stomach emptying(gastroesophageal reflux disease), who have failed to respond to standard therapy

Conditions

  • Digestive System Disease

Interventions

OTHER

Domperidone

Domperidone dosage may be increased depending on how well the patient responds. However before increasing the dosage, patients will have follow-up EKG to evaluate any possible side effects including irregular heartbeats.

Sponsors & Collaborators

  • Mt. Sinai Medical Center, Miami

    lead OTHER

Principal Investigators

  • Jamie S. Barkin, M.D. · Mt. Sinai Medical Center

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-12-31
Primary Completion
2015-02-19
Completion
2015-02-19

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01844622 on ClinicalTrials.gov